Sign In
Buy KRMD
$4.13
+0.270 (+6.99%)
At Close: Jun 23, 2026
Head to Head Review: KORU Medical Systems (NASDAQ:KRMD) and Veeva Systems (NYSE:VEEV)
02:20am, Wednesday, 03'rd Dec 2025
Veeva Systems (NYSE: VEEV - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two busines
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large
KORU Medical Systems to Participate in Upcoming Investor Conferences
08:00am, Thursday, 13'th Nov 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commer
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
08:41pm, Wednesday, 12'th Nov 2025
KORU Medical Systems, Inc. ( KRMD ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Linda Tharby - President, CEO & Director Tom Adams - CFO, Secretary & Treasurer Conference
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates
07:00pm, Wednesday, 12'th Nov 2025
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
04:05pm, Wednesday, 12'th Nov 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and comm
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
04:05pm, Tuesday, 04'th Nov 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
04:05pm, Wednesday, 22'nd Oct 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and comm
KORU Medical Systems (NASDAQ:KRMD) Shares Up 2.2% – Here’s What Happened
02:18am, Tuesday, 21'st Oct 2025
Shares of KORU Medical Systems, Inc. (NASDAQ: KRMD - Get Free Report) shot up 2.2% on Monday. The company traded as high as $4.15 and last traded at $4.14. 35,302 shares traded hands during mid-day tr
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
08:00am, Thursday, 18'th Sep 2025
DENVER & MAHWAH, N.J.--(BUSINESS WIRE)--ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ: KRMD) today jointly announced an agreement leveraging KORU Medical's FreedomEDGE® infusion sy
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
01:00pm, Thursday, 28'th Aug 2025
Does KORU Medical Systems, Inc. (KRMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Cirtec Medical Announces Appointment of New Chief Executive Officer
12:59pm, Thursday, 28'th Aug 2025
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is
KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript
03:23am, Thursday, 07'th Aug 2025
KORU Medical Systems, Inc. (NASDAQ:KRMD ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Linda M. Tharby - President, CEO & Director Thomas Adams - CFO, Secretary & Tr
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
07:40pm, Wednesday, 06'th Aug 2025
KORU Medical Systems, Inc. (KRMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.02 per share a year ago.
KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance
04:05pm, Wednesday, 06'th Aug 2025
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and comm
